Camp4 Therapeutics (CAMP) Interest & Investment Income (2023 - 2026)
Camp4 Therapeutics recorded quarterly Interest & Investment Income of $910000.0 in Q1 2026, up 28.17% quarter-over-quarter from $710000.0 in Q4 2025, and up 54.76% year-over-year from $588000.0 in Q1 2025.
Camp4 Therapeutics' Interest & Investment Income history runs 4 years deep, the most recent figure standing at $910000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 54.76% year-over-year to $910000.0; the TTM figure through Mar 2026 stood at $2.5 million (up 63.89% YoY), while the FY2025 annual figure was $2.2 million, up 63.46% from the prior year.
- Interest & Investment Income came in at $910000.0 for Q1 2026 at Camp4 Therapeutics, up from $710000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $910000.0 in Q1 2026 to a low of $94000.0 in Q3 2024.
- A 4-year average of $515636.4 and a median of $569000.0 in 2023 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income tumbled 86.36% in 2024 and soared 350.0% in 2025, its largest moves.
- Camp4 Therapeutics' Interest & Investment Income stood at $569000.0 in 2023, then climbed by 7.21% to $610000.0 in 2024, then grew by 16.39% to $710000.0 in 2025, then gained by 28.17% to $910000.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $910000.0, $710000.0, and $423000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Camp4 Therapeutics | 245.89 Mn | 245.89 Mn | - | 910,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 910,000.00 |
| Dec 31, 2025 | 710,000.00 |
| Sep 30, 2025 | 423,000.00 |
| Jun 30, 2025 | 453,000.00 |
| Mar 31, 2025 | 588,000.00 |
| Dec 31, 2024 | 610,000.00 |
| Sep 30, 2024 | 94,000.00 |
| Jun 30, 2024 | 231,000.00 |
| Mar 31, 2024 | 395,000.00 |
| Dec 31, 2023 | 569,000.00 |
| Sep 30, 2023 | 689,000.00 |